(Q27670633)

English

Structural features underlying the selectivity of the kinase inhibitors NBC and dNBC: role of a nitro group that discriminates between CK2 and DYRK1A

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

0 references

Structural features underlying the selectivity of the kinase inhibitors NBC and dNBC: role of a nitro group that discriminates between CK2 and DYRK1A (English)

0 references

4

0 references

Marco Mazzorana

object named as

Marco Mazzorana

2

0 references

object named as

Mario A Pagano

6

0 references

object named as

Giorgio Cozza

5

0 references

Lorenzo A Pinna

object named as

Lorenzo A Pinna

10

0 references

object named as

Stefania Sarno

1

0 references

author name string

Ryan Traynor

3

0 references

Flavio Meggio

7

0 references

Giuseppe Zagotto

8

0 references

Roberto Battistutta

9

0 references

publication date

February 2012

0 references

Cellular and Molecular Life Sciences

0 references

69

0 references

3

0 references

449-60

0 references

The druggable genome

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0758-7

21 January 2018

The protein kinase complement of the human genome

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0758-7

21 January 2018

Extraordinary pleiotropy of protein kinase CK2 revealed by weblogo phosphoproteome analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0758-7

21 January 2018

Variable contribution of protein kinases to the generation of the human phosphoproteome: a global weblogo analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0758-7

21 January 2018

Protein kinase CK2 in health and disease: CK2 and its role in Wnt and NF-kappaB signaling: linking development and cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0758-7

21 January 2018

Protein kinase CK2 in human diseases.

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0758-7

21 January 2018

Protein kinase CK2 as a druggable target

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0758-7

21 January 2018

Addiction to protein kinase CK2: a common denominator of diverse cancer cells?

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0758-7

21 January 2018

PTEN posttranslational inactivation and hyperactivation of the PI3K/Akt pathway sustain primary T cell leukemia viability

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0758-7

21 January 2018

Multiple myeloma cell survival relies on high activity of protein kinase CK2.

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0758-7

21 January 2018

Protein kinase CK2alpha as an unfavorable prognostic marker and novel therapeutic target in acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0758-7

21 January 2018

Non-oncogene addiction and the stress phenotype of cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0758-7

21 January 2018

Emergence of protein kinase CK2 as a key target in cancer therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0758-7

21 January 2018

Features and potentials of ATP-site directed CK2 inhibitors

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0758-7

21 January 2018

Too much of a good thing: the role of protein kinase CK2 in tumorigenesis and prospects for therapeutic inhibition of CK2.

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0758-7

21 January 2018

A structural insight into CK2 inhibition

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0758-7

21 January 2018

Protein kinase CK2 in health and disease: Structural bases of protein kinase CK2 inhibition

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0758-7

21 January 2018

The selectivity of inhibitors of protein kinase CK2: an update

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0758-7

21 January 2018

Coumarin as attractive casein kinase 2 (CK2) inhibitor scaffold: an integrate approach to elucidate the putative binding motif and explain structure-activity relationships

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0758-7

21 January 2018

Inhibition of protein kinase CK2 by condensed polyphenolic derivatives. An in vitro and in vivo study

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0758-7

21 January 2018

Optimization of protein kinase CK2 inhibitors derived from 4,5,6,7-tetrabromobenzimidazole

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0758-7

21 January 2018

The selectivity of protein kinase inhibitors: a further update

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0758-7

21 January 2018

Gini coefficient: a new way to express selectivity of kinase inhibitors against a family of kinases

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0758-7

21 January 2018

Structural features underlying selective inhibition of protein kinase CK2 by ATP site-directed tetrabromo-2-benzotriazole

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0758-7

21 January 2018

PHENIX: a comprehensive Python-based system for macromolecular structure solution

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0758-7

21 January 2018

Features and development of Coot

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0758-7

21 January 2018

Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0758-7

21 January 2018

Inhibition of protein kinase CK2 by anthraquinone-related compounds. A structural insight

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0758-7

21 January 2018

Dyrk1A-mediated phosphorylation of Presenilin 1: a functional link between Down syndrome and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0758-7

21 January 2018

Protein kinase CK2--a key suppressor of apoptosis

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0758-7

21 January 2018

Identification of Ellagic Acid as Potent Inhibitor of Protein Kinase CK2: A Successful Example of a Virtual Screening Application

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0758-7

21 January 2018

Protein Kinase CK2 Mutants Defective in Substrate Recognition

1 reference

https://api.crossref.org/works/10.1007%2FS00018-011-0758-7

21 January 2018

Specificity determinants of substrate recognition by the protein kinase DYRK1A

1 reference

https://pubmed.ncbi.nlm.nih.gov/21720886

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The CCP4 suite: programs for protein crystallography

1 reference

https://pubmed.ncbi.nlm.nih.gov/21720886

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endogenous phosphate acceptor proteins for rat liver cytosolic casein kinases

1 reference

https://pubmed.ncbi.nlm.nih.gov/21720886

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00018-011-0758-7

0 references

Dimensions Publication ID

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q27670633&oldid=2177401105"